文献速递胸部肿瘤

肿瘤细胞在新型非小细胞肺癌肿瘤微环境体外共培养模型中调控巨噬细胞表型

Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment.
PubMed 文献 · J Thorac Oncol · 2022-07-05

研究建立包含患者来源非小细胞肺癌细胞系、人癌相关成纤维细胞和小鼠巨噬细胞的体外共培养模型,检测72个细胞系对巨噬细胞表型的诱导。最常高诱导的巨噬细胞相关基因为精氨酸酶-1(Arg1),呈免疫抑制M2样表型,且不依赖临床病理因素;高诱导Arg1的细胞系在体内异种移植瘤中Arg1+巨噬细胞密度显著升高,匹配的TCGA临床样本M2:M1比值显著更高(p=0.0361)。

要点

  • 72个患者来源NSCLC细胞系共培养后最常高诱导巨噬细胞Arg1表达,呈M2样免疫抑制表型。
  • Arg1高诱导与主要临床病理因素及致癌基因型无关,匹配TCGA样本中M2:M1比值亦不受影响。
  • 高Arg1诱导细胞系体内异种移植瘤Arg1+巨噬细胞密度显著升高,匹配TCGA样本M2:M1比值显著更高(p=0.0361)。

核心结论

  • 在体外共培养模型中,大量患者来源NSCLC细胞系最常诱导共培养小鼠巨噬细胞高表达Arg1,且独立于主要临床病理和致癌基因型相关因素。
  • 与Arg1高诱导细胞系匹配的TCGA肿瘤含更高M2:M1巨噬细胞比值,该体外模型可重现个体NSCLC对巨噬细胞表型的调控并与临床样本巨噬细胞极化相关。

研究设计与样本

  • 研究建立体外共培养模型,由分子和临床注释的患者来源NSCLC细胞系、人癌相关成纤维细胞和小鼠巨噬细胞组成,共研究72个NSCLC细胞系。
  • 通过定量实时聚合酶链反应研究诱导的巨噬细胞表型,并用NSCLC异种移植瘤的定量免疫组化和TCGA匹配患者肿瘤进行验证。

主要发现

  • 最频繁高诱导的巨噬细胞相关基因为Arg1,反映免疫抑制M2样表型,且独立于多种临床病理因素。
  • 匹配TCGA样本中M2:M1比值亦不受临床病理因素影响。
  • 高Arg1诱导细胞系建立的异种移植瘤中Arg1+巨噬细胞密度显著升高。
  • 与高Arg1诱导NSCLC细胞系匹配的TCGA临床样本M2:M1巨噬细胞比值显著更高(p=0.0361)。

临床怎么用

  • 作者认为该体外模型可重复地表征个体NSCLC如何调控巨噬细胞表型,与临床样本中巨噬细胞极化相关,并可作为进一步研究巨噬细胞特异性治疗策略的易用平台。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Macrophage phenotype in the tumor microenvironment correlates with prognosis in NSCLC. Immunosuppressive macrophages promote tumor progression, whereas proinflammatory macrophages may drive an antitumor immune response. How individual NSCLCs affect macrophage phenotype is a major knowledge gap. METHODS: To systematically study the impact of lung cancer cells on macrophage phenotypes, we developed an in vitro co-culture model that consisted of molecularly and clinically annotated patient-derived NSCLC lines, human cancer-associated fibroblasts, and murine macrophages. Induced macrophage phenotype was studied through quantitative real-time polymerase chain reaction and validated in vivo using NSCLC xenografts through quantitative immunohistochemistry and clinically with The Cancer Genome Atlas (TCGA)-"matched" patient tumors. RESULTS: A total of 72 NSCLC cell lines were studied. The most frequent highly induced macrophage-related gene was Arginase-1, reflecting an immunosuppressive M2-like phenotype. This was independent of multiple clinicopathologic factors, which also did not affect M2:M1 ratios in matched TCGA samples. In vivo, xenograft tumors established from high Arginase-1-inducing lines (Arghi) had a significantly elevated density of Arg1+ macrophages. Matched TCGA clinical samples to Arghi NSCLC lines had a significantly higher ratio of M2:M1 macrophages (p = 0.0361). CONCLUSIONS: In our in vitro co-culture model, a large panel of patient-derived NSCLC lines most frequently induced high-expression Arginase-1 in co-cultured mouse macrophages, independent of major clinicopathologic and oncogenotype-related factors. Arghi cluster-matched TCGA tumors contained a higher ratio of M2:M1 macrophages. Thus, this in vitro model reproducibly characterizes how individual NSCLC modulates macrophage phenotype, correlates with macrophage polarization in clinical samples, and can serve as an accessible platform for further investigation of macrophage-specific therapeutic strategies.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Park JV, Chandra R, Cai L, et al. Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment. J Thorac Oncol. 2022. PMID: 35798240. doi:10.1016/j.jtho.2022.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。